Sysmex Corporation, a manufacturer of medical equipment and devices, has signed deals of joint development and investment with biotechnology startup ThinkCyte for the production and sale of a new artificial intelligence-enabled cell analysis technology for in-vitro diagnostics.
WHAT IT'S FOR
Sysmex has been acquiring technologies for analysing cells, genes, and proteins with a high degree of...
